Sun Pharma Halol unit receives UK clearance: Report
Sun Pharmaceutical Industries' Halol unit has received clearance from the UK’s pharma regulatory body, reported a leading news daily.
The company has got clearance for good manufacturing practices as directed by the UK’s Medicines and Healthcare Products Regulatory Agency, said the report. However, Sun Pharma has not commented on the report.
The company’s Halol manufacturing unit has faced regulatory issues from the U.S. Food and Drug Administration (USFDA). In December 2016, USFDA had issued a warning letter to the plant for failing to prevent microbiological contamination.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd